These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3643214

  • 1. Control of muscle differentiation in BC3H1 cells by fibroblast growth factor and vanadate.
    Wice B, Milbrandt J, Glaser L.
    J Biol Chem; 1987 Feb 05; 262(4):1810-7. PubMed ID: 3643214
    [Abstract] [Full Text] [Related]

  • 2. Control by fibroblast growth factor of differentiation in the BC3H1 muscle cell line.
    Lathrop B, Olson E, Glaser L.
    J Cell Biol; 1985 May 05; 100(5):1540-7. PubMed ID: 3988800
    [Abstract] [Full Text] [Related]

  • 3. Control of differentiation in BC3H1 muscle cells.
    Glaser L, Wice B.
    Environ Health Perspect; 1989 Mar 05; 80():143-8. PubMed ID: 2924753
    [Abstract] [Full Text] [Related]

  • 4. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation.
    Spizz G, Roman D, Strauss A, Olson EN.
    J Biol Chem; 1986 Jul 15; 261(20):9483-8. PubMed ID: 3722206
    [Abstract] [Full Text] [Related]

  • 5. Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways.
    Hu JS, Olson EN.
    J Biol Chem; 1988 Dec 25; 263(36):19670-7. PubMed ID: 2461941
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor controls smooth muscle alpha-isoactin expression in BC3H1 cells.
    Wang YC, Rubenstein PA.
    J Cell Biol; 1988 Mar 25; 106(3):797-803. PubMed ID: 3279054
    [Abstract] [Full Text] [Related]

  • 7. Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells.
    Olson EN, Caldwell KL, Gordon JI, Glaser L.
    J Biol Chem; 1983 Feb 25; 258(4):2644-52. PubMed ID: 6337159
    [Abstract] [Full Text] [Related]

  • 8. Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. II. Two signaling pathways distinguished by pertussis toxin and a potential role for the ras oncogene.
    Kelvin DJ, Simard G, Sue-A-Quan A, Connolly JA.
    J Cell Biol; 1989 Jan 25; 108(1):169-76. PubMed ID: 2492022
    [Abstract] [Full Text] [Related]

  • 9. Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured rat aortic smooth muscle cells.
    Blank RS, Thompson MM, Owens GK.
    J Cell Biol; 1988 Jul 25; 107(1):299-306. PubMed ID: 3392101
    [Abstract] [Full Text] [Related]

  • 10. Adrenergic regulation of c-fos expression in cultured BC3H1 muscle cells.
    Barka T, van der Noen H, Gresik EW.
    Exp Cell Res; 1989 Dec 25; 185(2):419-35. PubMed ID: 2557227
    [Abstract] [Full Text] [Related]

  • 11. Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. I. A pertussis toxin-sensitive pathway is involved.
    Kelvin DJ, Simard G, Tai HH, Yamaguchi TP, Connolly JA.
    J Cell Biol; 1989 Jan 25; 108(1):159-67. PubMed ID: 2536032
    [Abstract] [Full Text] [Related]

  • 12. Control of myogenic differentiation by fibroblast growth factor is mediated by position in the G1 phase of the cell cycle.
    Lathrop B, Thomas K, Glaser L.
    J Cell Biol; 1985 Dec 25; 101(6):2194-8. PubMed ID: 4066754
    [Abstract] [Full Text] [Related]

  • 13. Characterization of actin mRNA levels during BC3H1 cell differentiation.
    Strauch AR, Offord JD, Chalkley R, Rubenstein PA.
    J Biol Chem; 1986 Jan 15; 261(2):849-55. PubMed ID: 3941103
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of myogenic differentiation by fibroblast growth factor or type beta transforming growth factor does not require persistent c-myc expression.
    Spizz G, Hu JS, Olson EN.
    Dev Biol; 1987 Oct 15; 123(2):500-7. PubMed ID: 3477514
    [Abstract] [Full Text] [Related]

  • 15. Actin isoform utilization during differentiation and remodeling of BC3H1 myogenic cells.
    Qu G, Yan H, Strauch AR.
    J Cell Biochem; 1997 Dec 15; 67(4):514-27. PubMed ID: 9383710
    [Abstract] [Full Text] [Related]

  • 16. The expression of sarcomeric muscle-specific contractile protein genes in BC3H1 cells: BC3H1 cells resemble skeletal myoblasts that are defective for commitment to terminal differentiation.
    Taubman MB, Smith CW, Izumo S, Grant JW, Endo T, Andreadis A, Nadal-Ginard B.
    J Cell Biol; 1989 May 15; 108(5):1799-806. PubMed ID: 2715180
    [Abstract] [Full Text] [Related]

  • 17. Sequential expression of smooth muscle and sarcomeric alpha-actin isoforms during BC3H1 cell differentiation.
    Strauch AR, Reeser JC.
    J Biol Chem; 1989 May 15; 264(14):8345-55. PubMed ID: 2470744
    [Abstract] [Full Text] [Related]

  • 18. Substrate-associated macromolecules promote cytodifferentiation of BC3H1 myogenic cells.
    Strauch AR, Berman MD, Miller HR.
    J Cell Physiol; 1991 Mar 15; 146(3):337-48. PubMed ID: 1708777
    [Abstract] [Full Text] [Related]

  • 19. Mitogens and protein synthesis inhibitors induce ornithine decarboxylase gene transcription through separate mechanisms in the BC3H1 muscle cell line.
    Olson EN, Spizz G.
    Mol Cell Biol; 1986 Aug 15; 6(8):2792-9. PubMed ID: 3785214
    [Abstract] [Full Text] [Related]

  • 20. An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal.
    Payne PA, Olson EN, Hsiau P, Roberts R, Perryman MB, Schneider MD.
    Proc Natl Acad Sci U S A; 1987 Dec 15; 84(24):8956-60. PubMed ID: 3122209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.